InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.7900
0.00 (0.00%)
Mar 13, 2026, 4:00 PM EDT - Market closed
InterCure Market Cap
InterCure has a market cap or net worth of $37.26 million as of March 13, 2026. Its market cap has decreased by -52.04% in one year.
Market Cap
37.26M
Enterprise Value
75.18M
1-Year Change
-52.04%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $37.26M, an increase of 1,991.78%. That is a compound annual growth rate of 22.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 43.61M | -21.43% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Oncology | 71.71M |
| Incannex Healthcare | 46.58M |
| Cumberland Pharmaceuticals | 45.47M |
| SCYNEXIS | 38.36M |
| Zhengye Biotechnology Holding | 37.17M |
| Talphera | 37.14M |
| Rockwell Medical | 35.31M |
| BioXcel Therapeutics | 32.59M |